<?xml version="1.0" encoding="UTF-8"?>
<notes notes-type="ethics">
 <title>Compliance with ethical standards</title>
 <notes id="FPar1" notes-type="COI-statement">
  <title>Conflict of interest</title>
  <p id="Par25">F.T. has received research support and honoraria from Amgen, Bayer, Boehringer Ingelheim, Elpen, Lilly, Menarini, Merck, Novartis, Sanofi, Servier, Vianex, and WinMedica.</p>
  <p id="Par26">R.C.S. has received research funding from Covia, Amgen, advisory board Medtronic, advisor and steering committee Cardiac Dimensions, steering committee Novartis.</p>
  <p id="Par27">A.X. has received honoraria from Novartis.</p>
  <p id="Par28">J.B. has received research support from the National Institutes of Health, Patient Centered Outcomes Research Institute and the European Union. He serves as a consultant for Amgen, Array, Astra Zeneca, Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, CVRx, G3 Pharmaceutical, Innolife, Janssen, LinaNova, Luitpold, Medtronic, Merck, Novartis, NovoNordisk, Relypsa, Roche, Sanofi, StealthPeptide, V-Wave Limited, Vifor, and ZS Pharma.</p>
  <p id="Par29">H.B. has no disclosures.</p>
 </notes>
</notes>
